Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
Public ClinicalTrials.gov record NCT01059539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with bipolar I disorder.
Study identification
- NCT ID
- NCT01059539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 403 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2010
- Primary completion
- Feb 28, 2012
- Completion
- Feb 28, 2012
- Last update posted
- Jun 12, 2019
2010 – 2012
United States locations
- U.S. sites
- 24
- U.S. states
- 12
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 015 | Springdale | Arkansas | 72764 | — |
| Forest Investigative Site 010 | Carson | California | 90746 | — |
| Forest Investigative Site 020 | Cerritos | California | 90703 | — |
| Forest Investigative Site 009 | Escondido | California | 92025 | — |
| Forest Investigative Site 004 | Garden Grove | California | 92845 | — |
| Forest Investigative Site 016 | San Diego | California | 92102 | — |
| Forest Investigative Site 007 | Santa Ana | California | 92701 | — |
| Forest Investigative Site 023 | Washington D.C. | District of Columbia | 20016 | — |
| Forest Investigative Site 001 | Bradenton | Florida | 34208 | — |
| Forest Investigative Site 006 | Fort Lauderdale | Florida | 33308 | — |
| Forest Investigative Site 013 | Kissimmee | Florida | 34741 | — |
| Forest Investigative Site 021 | Rockville | Maryland | 20850 | — |
| Forest Investigative Site 024 | Flowood | Mississippi | 39232 | — |
| Forest Investigative Site 022 | Creve Coeur | Missouri | 63141 | — |
| Forest Investigative Site 003 | Saint Charles | Missouri | 63301 | — |
| Forest Investigative Site 025 | St Louis | Missouri | 63118 | — |
| Forest Investigative Site 012 | Las Vegas | Nevada | 89102 | — |
| Forest Investigative Site 002 | Willingboro | New Jersey | 08046 | — |
| Forest Investigative Site 005 | Cincinnati | Ohio | 45219 | — |
| Forest Investigative Site 011 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 017 | Austin | Texas | 78731 | — |
| Forest Investigative Site 014 | Austin | Texas | 78754 | — |
| Forest Investigative Site 018 | DeSoto | Texas | 75115 | — |
| Forest Investigative Site 019 | Houston | Texas | 77008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01059539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2019 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01059539 live on ClinicalTrials.gov.